Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Cited by (1,004)

Items 501–600 of 1,004

1. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)
   José Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Alfredo Cruz‐Lagunas, Tatiana Sofia Rodrı́guez-Reyna, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Diana Lizzeth Hernández-García, Eduardo Misael Choreño-Parra, Yalbi Itzel Balderas-Martínez, Mariana Esther Martínez-Sánchez et al. · 2021 · Frontiers in Immunology
2. Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis
   Raminder Aul, Dr Jessica Gates, Adrian Draper, Anne Dunleavy, Dr Sachelle Ruickbie, Helen Meredith, Nicola Walters, Cristiano Van Zeller, Victoria Taylor, Michael Bridgett et al. · 2021 · Respiratory Medicine
3. SARS-CoV-2: is there neuroinvasion?
   Conor McQuaid, Molly Brady, Rashid Deane · 2021 · Fluids and Barriers of the CNS
4. Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
   Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous, Lena Feige, Étienne Kornobis, Sylvain Levallois, Agnès Marchio, Lauriane Kergoat, David Hardy, Thomas Cokelaer et al. · 2021 · EMBO Molecular Medicine
5. Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial
   Shuang Zhou, Jun Feng, Qin Xie, Tingrong Huang, Xiaoming Xu, Daixing Zhou, Wen Zhang, Shuting Sun, Xudong Liu, Xinxin Wu et al. · 2021 · Phytomedicine
6. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
   Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, Chiara Mozzini · 2021 · Antioxidants
7. Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19
   Husam M. Salah, J. Mehta · 2021 · American Journal of Cardiology
8. Catecholamine physiology and its implications in patients with COVID-19
   Sriram Gubbi, Matthew A. Nazari, David Taïeb, Joanna Kłubo-Gwieździńska, Karel Pacák · 2020 · The Lancet Diabetes & Endocrinology
9. Kinetics of SARS-CoV-2 infection in the human upper and lower respiratory tracts and their relationship with infectiousness
   Ruian Ke, Carolin Zitzmann, Ruy Miguel Ribeiro, Alan S. Perelson · 2020 · medRxiv
10. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
    Calvin Chen Sheng, Debasis H Sahoo, Siddharth Pawan Dugar, Robier Aguillon Prada, Tom Kai Ming Wang, Ossama K. Abou Hassan, Danielle M. Brennan, Daniel A. Culver, Prabalini Rajendram, Abhijit Duggal et al. · 2020 · Clinical Cardiology
11. Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial
    Tornling, Göran, Batta, Rohit, Porter, Joanna C., Williams, Bryan, Bengtsson, Thomas, Parmar, Kartikeya, Kashiva, Reema, Hallberg, Anders, Cohrt, Anne Katrine, Westergaard, Kate et al. · 2021 · EClinicalMedicine
12. Association of vitamin D status with COVID-19 and its severity
    Jae Hyun Bae, Hun Jee Choe, Michael F. Holick, Soo Kyung Lim · 2022 · Reviews in Endocrine and Metabolic Disorders
13. Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study
    Manouchehr Avatef Fazeli, Leila Rezaei, Etrat Javadirad, Khosro Iranfar, Abbas Khosravi, Javad Amini Saman‎, Pardis Poursabbagh, Mohammad Rasoul Ghadami, Mohammad Mehdi Parandin, Amrollah Dehghani et al. · 2021 · Mycoses
14. Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers
    Ruixin Yang, Yingyan Yu · 2021 · International Journal of Biological Sciences
15. Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
    Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub · 2020 · Reviews in Medical Virology
16. Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research
    Lieuwe D. J. Bos, Antonio Artigas, Jean‐Michel Constantin, Laura A. Hagens, Nanon F. L. Heijnen, John Gerard Laffey, Nuala J. Meyer, Laurent Papazian, Lara Pisani, Marcus Josephus Schultz et al. · 2021 · European Respiratory Review
17. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
    Xiyuan Bai, Joseph A. Hippensteel, Alida Leavitt, James P. Maloney, John David Beckham, Cindy Garcia, Qing Li, Brian M. Freed, Diane J. Ordway, Robert A. Sandhaus et al. · 2020 · Medical Hypotheses
18. Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
    Alessia Longobardo, Cecilia Montanari, R. Shulman · 2020 · British Journal of Anaesthesia
19. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
    Perrine Janiaud, Cathrine Axfors, Janneke van ’t Hooft, Ramon T. Saccilotto, Arnav Agarwal, Christian Appenzeller‐Herzog, Despina G. Contopoulos‐Ioannidis, Valentin Danchev, Ulrich Dirnagl, Hannah Ewald et al. · 2020 · F1000Research
20. Timing of Intubation and In-Hospital Mortality in Patients With Coronavirus Disease 2019
    Jaime B. Hyman, Evan S. Leibner, Pranai Tandon, Natalia Egorova, Adel Bassily‐Marcus, Roopa D. Kohli-Seth, Varun Arvind, Helena L. Chang, Hung‐Mo Lin, Matthew A. Levin · 2020 · Critical Care Explorations
21. COVID‐19‐related disease severity in pregnancy
    Jennifer L. Thompson, Lynsa M. Nguyen, Kristen N. Noble, David Michael Aronoff · 2020 · American Journal of Reproductive Immunology
22. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
    F. Meyer-Almes · 2020 · Comput. Biol. Chem.
23. Psychiatric presentation of patients with acute SARS-CoV-2 infection: a retrospective review of 50 consecutive patients seen by a consultation-liaison psychiatry team.
    Iqbal, Yousaf, Al Abdulla, Majid Ali, Albrahim, Sultan, Latoo, Javed, Kumar, Rajeev, Haddad, Peter M. · 2020 · BJPsych Open
24. Cardiac corrected QT interval changes among patients treated for COVID-19 infection during the early phase of the pandemic
    Rubin, Geoffrey A., Desai, Amar D., Chai, Zilan, Wang, Aijin, Chen, Qixuan, Wang, Amy S., Kemal, Cameron, Baksh, Haajra, Biviano, Angelo, Dizon, Jose M. et al. · 2021 · JAMA Network Open
25. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
    Elsa Brunet-Ratnasingham, S. Anand, P. Gantner et al. · 2021 · medRxiv
26. The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic
    Pascale Khairallah, Nidhi Aggarwal, Ahmed A. Awan, Chandan Vangala, Medha Airy, Jenny Szu-Chin Pan, Bhamidipati V. R. Murthy, Wolfgang C. Winkelmayer­, Venkat Ramanathan · 2021 · Transplant International
27. Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis
    Saskia Ricks, Emily A. Kendall, David W. Dowdy, Jilian A. Sacks, Samuel G. Schumacher, Nimalan Arinaminpathy · 2021 · BMC Medicine
28. Combining Antivirals and Immunomodulators to Fight COVID-19
    Vincent Feuillet, Bruno Canard, Alain Trautmann · 2020 · Trends in Immunology
29. A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity
    Kunwar Singh, Sasha Mittal, Sumanth Gollapudi, Alexandra Butzmann, Jyoti Kumar, Robert Shigeo Ohgami · 2020 · International Journal of Laboratory Hematology
30. Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity
    Gijs H. Goossens, Dror Dicker, Nathalie J. Farpour‐Lambert, Gema Frühbeck, Dana Müllerová, Euan Woodward, Jens‐Christian Holm · 2020 · Obesity Facts
31. In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
    Sanju Sinha, Kuoyuan Cheng, Alejandro A. Schäffer, Kenneth Aldape, Eyal Schiff, Eytan Ruppin · 2020 · Molecular Systems Biology
32. Severe Infections Due to Respiratory Viruses
    Catia Cillóniz, Juan Manuel Pericàs, Jorge R. Rojas, Antoní Torres · 2022 · Seminars in Respiratory and Critical Care Medicine
33. Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID
    Matthew L. Plassmeyer, Oral Alpan, Michael J. Corley, Thomas A. Premeaux, Kimberleigh Lillard, Paige Coatney, Tina Vaziri, Suzan Michalsky, Alina P.S. Pang, Zaheer Bukhari et al. · 2021 · Allergy
34. Development and application of therapeutic antibodies against COVID-19
    Lin-jin Ning, H. B. Abagna, Qianhu Jiang, Siqi Liu, Jian Huang · 2021 · International Journal on Biological Sciences
35. Role of arachidonic cascade in COVID-19 infection: A review
    Md. Abdur Rahman Ripon, Dipty Rani Bhowmik, Mohammad Tohidul Amin, Mohammad Salim Hossain · 2021 · Prostaglandins & Other Lipid Mediators
36. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
    Sophie Juul, Emil Eik Nielsen, Joshua Buron Feinberg, Faiza Siddiqui, Caroline Barkholt Kamp, Emily Barot, Johan Holgersson, Niklas Nielsen, Peter Bentzer, Areti Angeliki Veroniki et al. · 2021 · PLoS ONE
37. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
    Ellen A. Gorman, Jonathan Edward Millar, Daniel Francis McAuley, Cecilia M. O’Kane · 2020 · Expert Review of Respiratory Medicine
38. Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
    Paola Magro, Isabella Zanella, Marta Pescarolo, Francesco Castelli, Eugenia Quirós-Roldán · 2020 · Biomedical Journal
39. Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study
    Jennifer Ann Frontera, Joseph Rahimian, Shadi R. Yaghi, Mengling Liu, Ariane K. Lewis, Adam de Havenon, Shraddha Mainali, Joshua Huang, Erica Scher, Thomas Wısnıewskı et al. · 2020 · Research Square
40. Clinical Significance of Timing of Intubation in Critically Ill Patients with COVID-19: A Multi-Center Retrospective Study
    Yong Hoon Lee, Keum-Ju Choi, Sun Ha Choi, Shin Yup Lee, Kyung Chan Kim, Eun Jin Kim, Jaehee Lee · 2020 · Journal of Clinical Medicine
41. MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale
    Paul Ellis Marik, Pierre D. Kory, Joseph Varón, Jose I. Iglesias, G. Umberto Meduri · 2020 · Expert Review of Anti-infective Therapy
42. COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
    Malin L. Hultcrantz, Joshua Ryan Richter, Cara Ann Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi Ashok Shah, Alexander M. Lesokhin et al. · 2020 · Blood Cancer Discovery
43. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them
    Martin J Burton, Jan Clarkson, Beatriz Goulão, Anne‐Marie Glenny, Andrew J. McBain, Anne GM Schilder, Katie E Webster, Helen V Worthington · 2020 · Cochrane Database of Systematic Reviews
44. Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19
    Fuhai Li, Adrianus C. M. Boon, Andrew P. Michelson, Randi E. Foraker, Ming Zhan, Philip Payne · 2022 · Scientific Reports
45. COVID‐19 and immunothrombosis: emerging understanding and clinical management
    Rebecca Shaw, Charlotte Ann Bradbury, Simon Timothy Abrams, Guozheng Wang, Cheng‐Hock Toh · 2021 · British Journal of Haematology
46. Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
    Leila Shahbaznejad, Alireza Davoudi, Gohar Eslami, John Seth Markowitz, Mohammad Reza Navaeifar, Fatemeh Hosseinzadeh, Faeze Sadat Movahedi, Mohammad Sadegh Rezai · 2021 · Clinical Therapeutics
47. Brief review of the mRNA vaccines COVID-19
    Antonio Vitiello, Francesco Ferrara · 2021 · Inflammopharmacology
48. Reactive arthritis after COVID-19
    Bo Langhoff Hønge, Marie‐Louise From Hermansen, Merete Storgaard · 2021 · BMJ Case Reports
49. COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
    Meijer, Eelco F. J., Dofferhoff, Anton S. M., Hoiting, Oscar, Meis, Jacques F. · 2021 · Mycoses
50. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots
    Moon Ley Tung, Bryce W. Q. Tan, Robin Cherian, Bharatendu Chandra · 2021 · Rheumatology Advances in Practice
51. Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19
    Shaul Lev, Tamar Gottesman, Gal Sahaf Levin, Doron Lederfein, Evgeny Berkov, Dror Diker, Aliza Zaidman, Amir Nutman, Tahel Ilan Ber, Alon Angel et al. · 2021 · PLoS ONE
52. A review on the advancements in the development of vaccines to combat coronavirus disease 2019
    Helen Onyeaka, Zainab Al-sharify, Maryam Y Ghadhban · 2021 · Clinical and experimental vaccine research
53. Increased Secondary Infection in COVID-19 Patients Treated with Steroids in New York City
    Reiichiro Obata, Tetsuro Maeda, Dahlia Rizk, Toshiki Kuno · 2020 · Japanese Journal of Infectious Diseases
54. Let fever do its job
    Sylwia Wrotek, Edmund Kenwood LeGrand, Artur Dzialuk, Joe Alcock · 2020 · Evolution Medicine and Public Health
55. Photodynamic therapy for COVID-19
    N. Kipshidze, Nick Yeo, Nodar Kipshidze · 2020 · Nature Photonics
56. Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome
    Michael A. Matthay, Katherine D. Wick · 2020 · Journal of Clinical Investigation
57. A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients’ Lives and Allografts
    Smaragdi Marinaki, Stathis Tsiakas, Maria Korogiannou, Konstantinos Grigorakos, Vassilios E Papalois, Ioannis N Boletis · 2020 · Journal of Clinical Medicine
58. Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19
    Brian C. Nelson, Justin C. Laracy, Sherif M Shoucri, Donald Dietz, Jason E Zucker, Nina M. Patel, Magdalena E. Sobieszczyk, Christine J. Kubin, Angela Gomez‐Simmonds · 2020 · Clinical Infectious Diseases
59. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
    D. Nicolau, M. Bafadhel · 2020 · The Lancet Respiratory Medicine
60. Asthma and COVID-19: a dangerous liaison?
    Carlo Lombardi, Federica Gani, Alvise Berti, Pasquale Comberiati, Diego Giampietro Peroni, Marcello Cottini · 2021 · Asthma Research and Practice
61. An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
    Álvaro Réa-Neto, Rafaella Stradiotto Bernardelli, Bruna Martins Dzivielevski Câmara, Fernanda Baeumle Reese, Marcos Vinícius Oliveira Queiroga, Mirella Cristine de Oliveira · 2021 · Scientific Reports
62. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle
    Jeff M.P. Holly, Kalina M. Biernacka, Nick A. Maskell, Claire M. Perks · 2020 · Frontiers in Endocrinology
63. Managing rheumatoid arthritis during COVID-19
    Rashmi Roongta, Alakendu Ghosh · 2020 · Clinical Rheumatology
64. Advances in the possible treatment of COVID-19: A review.
    Pankaj Chibber, Syed Assim Haq, Irfan Ahmed, Nusrit Iqbal Andrabi, Gurdarshan Singh · 2020 · European Journal of Pharmacology
65. Major haemorrhage: past, present and future
    A. Shah, V. Kerner, S. Stanworth · 2022 · Anaesthesia
66. Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy
    Nikolaos P. Daskalakis, Onno Cornelis Meijer, E. R. de Kloet · 2022 · Neurobiology of Stress
67. Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units
    Themoula Charalampous, Adela Alcolea-Medina, Luke B. Snell, Tom G. S. Williams, Rahul Batra, Christopher Alder, Andrea Telatin, Luigi Camporota, Christopher I. S. Meadows, Duncan L. A. Wyncoll et al. · 2021 · Genome Medicine
68. Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries
    Suwasin Udomkarnjananun, Stephen John Kerr, Natavudh Townamchai, Paweena Susantitaphong, Wasee Tulvatana, Kearkiat Praditpornsilpa, Somchai Eiam‐Ong, Yingyos Avihingsanon · 2021 · Scientific Reports
69. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity
    Zintis Inde, Ben A. Croker, Clarence Yapp, Gaurav N. Joshi, Johan K. E. Spetz, Cameron S. Fraser, Xingping Qin, Le Xu, B. Deskin, Elisa Ghelfi et al. · 2021 · Science Advances
70. Insights into SARS-CoV-2 Persistence and Its Relevance
    Belete Ayele Desimmie, Yonas Raru, Hesham Awadh, Peimei He, Samson Teka, Kara S. Willenburg · 2021 · Viruses
71. Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
    Ghady Haidar, John W. Mellors · 2021 · Clinical Infectious Diseases
72. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
    Caroline Huart, Carl Martin Philpott, Aytuğ Altundağ, Alexander Wieck Fjældstad, Johannes Frasnelli, Simon B. Gane, Julien Wen Hsieh, Eric H. Holbrook, Iordanis Konstantinidis, Basile Nicolas Landis et al. · 2021 · International Forum of Allergy & Rhinology
73. Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC
    H. Yoon, Rachel Bartash, I. Gendlina et al. · 2020 · medRxiv
74. COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia
    Garth William Strohbehn, Brian L. Heiss, Sherin Juliet Rouhani, Jonathan Trujillo, Jovian Yu, Alec J. Kacew, Emily F. Higgs, Jeffrey C. Bloodworth, Alexandra Cabanov, Rachel C. Wright et al. · 2020 · Clinical Pharmacology & Therapeutics
75. Sports Medicine Considerations During the COVID-19 Pandemic
    Mary K. Mulcahey, Arianna L. Gianakos, Angela M. Mercurio, Scott Alan Rodeo, Karen Michelle Sutton · 2020 · The American Journal of Sports Medicine
76. Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience
    Beatriz Domínguez‐Gil, Mario Fernández‐Ruiz, Domingo Hernández, Marta Crespo, Jordi Colmenero, Elisabeth Coll, Juan José Rubio · 2020 · Transplantation
77. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation
    Chanan Meydan, Nimrod Madrer, Hermona Soreq · 2020 · Frontiers in Immunology
78. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
    Joel M. Gelfand, April Wang Armstrong, Stacie J. Bell, George L. Anesi, Andrew Blauvelt, Cassandra M. Calabrese, Erica D. Dommasch, Steven R. Feldman, Dafna D. Gladman, Leon Kircik et al. · 2020 · Journal of the American Academy of Dermatology
79. Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
    Khalid Ibrahim Bzeizi, Maheeba Abdulla, Nafeesa Mohammed, Jehad AlQamish, Negar Jamshidi, Dieter Broering · 2021 · Scientific Reports
80. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
    E. Della Torre, M. Lanzillotta, C. Campochiaro et al. · 2021 · Frontiers in Immunology
81. Precision therapeutic targets for COVID-19
    Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd Eliot Golde, Benoit I. Giasson, Yuxing Xia · 2021 · Virology Journal
82. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa
    Bisi Bright, Chinedum Peace Babalola, Nadia Adjoa Sam-Agudu, Augustine Anayochukwu Onyeaghala, Adebola Olatunji, Ufuoma Aduh, Patrick O. Sobande, Trevor A. Crowell, Yenew Kebede Tebeje, Sunny Phillip et al. · 2021 · Globalization and Health
83. COVID 19 infection: Pediatric perspectives
    Adebayo Adeyinka, Keneisha Bailey, Louisdon Pierre, Noah P. Kondamudi · 2021 · Journal of the American College of Emergency Physicians Open
84. Therapeutic strategies to fight COVID‐19: Which is the status artis?
    Cristina Scavone, Annamaria Mascolo, Concetta Rafaniello, Liberata Sportiello, Ugo Trama, Alice Zoccoli, Francesca Futura Bernardi, Giorgio Racagni, Liberato Berrino, Giuseppe Castaldo et al. · 2021 · British Journal of Pharmacology
85. Possible treatment and strategies for COVID-19: review and assessment.
    N. Trivedi, A. Verma, D. Kumar · 2020 · European Review for Medical and Pharmacological Sciences
86. Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study
    Marco Falcone, Giusy Tiseo, Greta Barbieri, Valentina Galfo, Alessandro Russo, Agostino Virdis, Francesco Forfori, Francesco Corradi, Fabio Guarracino, Laura Carrozzi et al. · 2020 · Open Forum Infectious Diseases
87. Pathogenesis‐directed therapy of 2019 novel coronavirus disease
    Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu · 2020 · Journal of Medical Virology
88. Continuous Positive Airway Pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: A retrospective cohort study
    Sophie Alviset, Quentin Riller, Jérôme Aboab, Kelly Dilworth, Pierre-Antoine Billy, Yannis Lombardi, Mathilde Azzi, Luis Ferreira Vargas, Laurent Lainé, Mathilde Lermuzeaux et al. · 2020 · PLoS ONE
89. Glucocorticoid excess and COVID-19 disease
    Valentina Guarnotta, Rosario Ferrigno, Marianna Martino, Mattia Barbot, Andrea Maria Isidori, Carla Maria Scaroni, Angelo Ferrante, Giorgio Arnaldi, Rosario Pivonello, Carla Santos de Souza Giordano · 2020 · Reviews in Endocrine and Metabolic Disorders
90. COVID-19: Infection or Autoimmunity
    Timothy B. Icenogle · 2020 · Frontiers in Immunology
91. Management of epigenomic networks entailed in coronavirus infections and COVID-19
    Ranim El Baba, G. Herbein · 2020 · Clinical Epigenetics
92. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
    Sirle Saul, Shirit Einav · 2020 · ACS Infectious Diseases
93. In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project
    Pontus Hedberg, Miłosz Parczewski, Karol Serwin, Giulia Carla Marchetti, Francesca Bai, Björn‐Erik Ole Jensen, Joana P.V. Pereira, Francis A. Drobniewski, Henrik Reschreiter, Daniel Naumovas et al. · 2024 · The Lancet Regional Health - Europe
94. eARDS: A multi-center validation of an interpretable machine learning algorithm of early onset Acute Respiratory Distress Syndrome (ARDS) among critically ill adults with COVID-19
    Lakshya Singhal, Yash Garg, Philip Yang, Azade Tabaie, An-Kwok Ian Wong, Akram Mohammed, Lokesh K. Chinthala, Dipen Kadaria, Amik Sodhi, Andre L. Holder et al. · 2021 · PLoS ONE
95. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
    E. Franceschini, A. Cozzi-Lepri, A. Santoro et al. · 2021 · Microorganisms
96. Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
    Luis Garegnani, Eva Madrid A, Nicolás Meza · 2021 · BMJ Evidence-Based Medicine
97. Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
    David James Pinato, Lorenza Scotti, Alessandra Gennari, Emeline Colomba-Blameble, Saoirse Olivia Dolly, Angela Loizidou, John David Chester, Uma Mukherjee, Alberto Zambelli, Mark Bower et al. · 2021 · European Journal of Cancer
98. Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
    Andreas Kronbichler, Hans‐Joachim Anders, Gema Maria Fernandez Juarez, Jürgen Floege, Dimitrios S. Goumenos, Mårten Segelmark, Vladimı́r Tesař, Kültiğin Türkmen, Cees van Kooten, Annette N. Bruchfeld · 2021 · Nephrology Dialysis Transplantation
99. High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
    W. Cao, Xiaosheng Liu, Ke Hong et al. · 2021 · Frontiers in Immunology
100. Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)
     Thomas D. Filardo, Maria R. Khan, Noa Krawczyk, Hayley Galitzer, Savannah Karmen-Tuohy, Megan P. Coffee, Verity E. Schaye, Benjamin J. Eckhardt, Gabriel M. Cohen · 2020 · PLoS ONE